IT1178789B
(it)
*
|
1984-12-21 |
1987-09-16 |
Assorenti |
Peptidi retro-invertiti analoghi del potenziatore della bradichinina bpp 5a
|
IT1184317B
(it)
*
|
1985-02-05 |
1987-10-28 |
Eniricerche Spa |
Retro-inverso analoghi del peptide potenziatore della bradichina bpp5a
|
IT1184164B
(it)
*
|
1985-03-19 |
1987-10-22 |
Eniricerche Spa |
Triptidi ad azione ipotensiva e procedimento per la loro sintesi
|
IT1190389B
(it)
*
|
1985-09-19 |
1988-02-16 |
Eniricerche Spa |
Esapeptidi ad attivita' ipotensiva
|
ATE258188T1
(de)
*
|
1992-08-27 |
2004-02-15 |
Deakin Res Ltd |
Retro-, inverso-, und retro-inverso synthetische peptidanaloge
|
US5968895A
(en)
|
1996-12-11 |
1999-10-19 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
EP1052994A2
(de)
|
1998-02-02 |
2000-11-22 |
Trustees Of Tufts College |
Verwendung von dipetidylpeptidasehemmer zur regulierung des glukosemetabolismus
|
US6465495B1
(en)
|
1998-07-30 |
2002-10-15 |
Osi Pharmaceuticals, Inc. |
Preparation of pyridone-based phosphotyrosine mimetics and uses thereof
|
US6984719B1
(en)
|
1998-09-17 |
2006-01-10 |
Hospital Sainte-Justine |
Peptide antagonists of prostaglandin F2α receptor
|
US7396905B1
(en)
|
1999-05-21 |
2008-07-08 |
Mckeon Frank |
Calcipressins: endogenous inhibitors of calcineurin, uses and reagents related thereto
|
US20040235749A1
(en)
*
|
1999-09-15 |
2004-11-25 |
Sylvain Chemtob |
G-protein coupled receptor antagonists
|
US20050119454A1
(en)
*
|
2000-01-24 |
2005-06-02 |
The Cielo Institute, Inc. |
Algorithmic design of peptides for binding and/or modulation of the functions of receptors and/or other proteins
|
US6560542B1
(en)
*
|
2000-01-24 |
2003-05-06 |
The Cielo Institute |
Algorithmic design of peptides for binding and/or modulation of the functions of receptors and/or other proteins
|
US6865492B2
(en)
*
|
2000-01-24 |
2005-03-08 |
The Cielo Institute, Inc. |
Algorithmic design of peptides for binding and/or modulation of the functions of receptors and/or other proteins
|
BR0101088A
(pt)
*
|
2001-03-19 |
2003-03-18 |
Biolab Sanus Farmaceutica Ltda |
Processo de isolamento e purificação de peptìdeos inibidores das vasopeptidases, com especificidade para o sìtio carboxìlico da enzima conversora da angiotensina, secretados pelas glândulas do veneno de serpentes (bpps), particularmente bothrops jararaca, ou produzidos endogenamente (evasins) possuindo ação vasodilatadora e anti-hipertensiva; processo de determinação da sequência de amido-ácidos dos peptìdios inibidores secretados pela glândula de veneno de serpentes (bpps) ou endógenos (evasins); processo de determinação da sequência de aminoácidos dos bpps por dedução do cdna dos precursores dessas moléculas expressos em tecidos de serpentes, especificamente bothrops jararaca. processo de determinação da sequência de aminoácidos dos evasins por dedução do cdna dos precursores dessas moléculas expressos em tecidos de serpentes, especificamente bothrops jararaca, processo de amplificação do cdna a partir das bibliotecas de cdna de pâncreas e/ou cérebro de serpentes, especificamente bothrops jararaca; processo de sìntese em fase sólida de peptìdeos inibidores das vasopeptidases com ação vasodilatadora e anti-hipertensiva, peptìdeos inibidores das vasopeptidases com ação anti-hipertensiva; utilização dos peptìdeos inibidores das vaso peptidases com ação vasodilatadora e anti-hipertensiva na obtenção de composições farmacêuticas; processo de determinação da atividade inibitória sobre as vasopeptidases e de atividade biológica sobre músculo liso, sistema cardiovascular e microcirculatório.
|
JP5010798B2
(ja)
|
2001-10-03 |
2012-08-29 |
プレジデント・アンド・フェローズ・オブ・ハーバード・カレッジ |
自己免疫疾患を抑制するためのコポリマー、及びその使用方法
|
EP2769715A3
(de)
|
2001-11-26 |
2014-09-17 |
Trustees Of Tufts College |
Verfahren zur Behandlung von Autoimmunkrankheiten und damit zusammenhängende Reagenzien
|
CA2468192A1
(en)
*
|
2001-11-26 |
2003-06-05 |
Trustees Of Tufts College |
Peptidomimetic inhibitors of post-proline cleaving enzymes
|
US6935959B2
(en)
*
|
2002-05-16 |
2005-08-30 |
Microsoft Corporation |
Use of multiple player real-time voice communications on a gaming device
|
US7521530B2
(en)
|
2002-06-11 |
2009-04-21 |
Universite De Montreal |
Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2α receptor
|
US7521481B2
(en)
|
2003-02-27 |
2009-04-21 |
Mclaurin Joanne |
Methods of preventing, treating and diagnosing disorders of protein aggregation
|
EP1697399B1
(de)
|
2003-12-12 |
2016-11-23 |
GOVERNMENT OF THE UNITED STATES OF AMERICA, as repr. by THE SECR. OF THE DEPT. OF HEALTH AND HUMAN SERVICES AND HIS SUCCESSORS |
Epitop humaner zytotoxischer t-lymphozyten und dessen agonistenepitop aus der nichtvariablen zahl der tandem-wiederholungssequenz von muc-1
|
US7491263B2
(en)
|
2004-04-05 |
2009-02-17 |
Technology Innovation, Llc |
Storage assembly
|
WO2006019904A1
(en)
|
2004-07-14 |
2006-02-23 |
University Of Utha Research Foundation |
Netrin-related compositions and uses
|
DE102004037356B4
(de)
*
|
2004-07-30 |
2017-11-23 |
Ansaldo Energia Ip Uk Limited |
Wandstruktur zur Begrenzung eines Heißgaspfads
|
ZA200704872B
(en)
|
2004-11-17 |
2008-12-31 |
Mclaurin Joanne |
Compositions comprising scyllo-inositol derivatives and methods to treat disorders of protein aggregation
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
EP2796146B1
(de)
|
2005-02-25 |
2016-11-09 |
University of Utah Research Foundation |
Tropoelastin zur Förderung der Endothelzellenadhäsion oder -migration
|
WO2007016763A1
(en)
|
2005-08-05 |
2007-02-15 |
Pharmagap Inc. |
Peptides targeted to protein kinase c isoforms and uses thereof
|
WO2007109583A2
(en)
|
2006-03-17 |
2007-09-27 |
The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject
|
EP2275142A3
(de)
|
2006-06-30 |
2011-05-11 |
Andre Koltermann |
Konjugate für Krebs-Immuntherapie
|
ES2425264T3
(es)
|
2007-04-12 |
2013-10-14 |
Waratah Pharmaceuticals, Inc. |
Uso de derivados de ciclohexanohexol en el tratamiento de enfermedades oculares
|
US8026208B2
(en)
*
|
2007-06-27 |
2011-09-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Peptide tyrosinase inhibitors and uses thereof
|
JP5587772B2
(ja)
*
|
2007-06-27 |
2014-09-10 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
オリゴペプチドチロシナーゼインヒビターおよびその使用
|
JP2010534828A
(ja)
*
|
2007-07-23 |
2010-11-11 |
ビオエクセル エスピーエー |
スクリーニング、療法及び診断
|
GB0821941D0
(en)
|
2008-12-01 |
2009-01-07 |
Renovo Ltd |
Non-surgical improvements of scars
|
AU2011274474B2
(en)
|
2010-07-09 |
2015-06-18 |
Dana-Farber Cancer Institute, Inc. |
Stabilized insulinotropic peptides and methods of use
|
EP3272769B1
(de)
|
2012-01-26 |
2020-06-17 |
Christopher J. Soares |
Peptidantagonisten aus der calcitonin-cgrp-familie von peptidhormonen und deren verwendung
|
ES2664237T3
(es)
|
2012-03-13 |
2018-04-18 |
James Cook University |
Ac-TMP-2 para su uso en el tratamiento de la inflamación
|
JP6549554B2
(ja)
|
2013-03-15 |
2019-07-24 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
コレステロール流出を刺激する、減少した毒性を有するペプチド
|
AU2014324093A1
(en)
|
2013-09-18 |
2016-04-28 |
James Cook University |
Anti-inflammatory proteins and methods of use
|
WO2016197018A1
(en)
|
2015-06-05 |
2016-12-08 |
Ibio, Inc. |
Endostatin fragments and variants for use in treating fibrosis
|
GB201609083D0
(en)
|
2016-05-24 |
2016-07-06 |
Syntab Therapeutics Gmbh |
Synthetic compound
|
ES2965087T3
(es)
|
2016-09-02 |
2024-04-10 |
Soares Christopher J |
Uso de antagonistas de receptor de CGRP en el tratamiento de glaucoma
|
EP3630153A2
(de)
|
2017-05-22 |
2020-04-08 |
National Hellenic Research Foundation |
Makrocyclische modulatoren von krankheitsassoziierter proteinmissfaltung und aggregation
|